ZBD: The approval notice for the listing application of fumaric acid lupatadine as a chemical raw material drug has been obtained
I'm PortAI, I can summarize articles.
ZBD announced that its Jixi branch has received the approval notice for the marketing application of Fumaric Acid Lurasidone chemical raw materials issued by the National Medical Products Administration. Fumaric Acid Lurasidone is a long-acting antihistamine that acts on H1 receptors. The company has invested approximately RMB 6.6526 million in research and development expenses for this project
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments